Annual Cash & Cash Equivalents
$81.30 M
+$19.68 M+31.95%
31 December 2023
Summary:
Praxis Precision Medicines annual cash & cash equivalents is currently $81.30 million, with the most recent change of +$19.68 million (+31.95%) on 31 December 2023. During the last 3 years, it has fallen by -$215.31 million (-72.59%). PRAX annual cash & cash equivalents is now -72.59% below its all-time high of $296.61 million, reached on 31 December 2020.PRAX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$168.65 M
+$23.50 M+16.19%
30 September 2024
Summary:
Praxis Precision Medicines quarterly cash and cash equivalents is currently $168.65 million, with the most recent change of +$23.50 million (+16.19%) on 30 September 2024. Over the past year, it has increased by +$67.56 million (+66.83%). PRAX quarterly cash and cash equivalents is now -43.14% below its all-time high of $296.61 million, reached on 31 December 2020.PRAX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRAX Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +31.9% | +66.8% |
| 3 y3 years | -72.6% | +1.8% |
| 5 y5 years | +352.9% | - |
PRAX Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -72.6% | +31.9% | at high | +200.9% |
| 5 y | 5 years | -72.6% | +352.9% | -43.1% | +754.0% |
| alltime | all time | -72.6% | +352.9% | -43.1% | +754.0% |
Praxis Precision Medicines Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $168.65 M(+16.2%) |
| June 2024 | - | $145.14 M(-4.5%) |
| Mar 2024 | - | $151.98 M(+86.9%) |
| Dec 2023 | $81.30 M(+31.9%) | $81.30 M(-19.6%) |
| Sept 2023 | - | $101.08 M(-18.7%) |
| June 2023 | - | $124.30 M(+53.8%) |
| Mar 2023 | - | $80.84 M(+31.2%) |
| Dec 2022 | $61.62 M | $61.62 M(-1.3%) |
| Sept 2022 | - | $62.44 M(+11.4%) |
| June 2022 | - | $56.04 M(-28.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $77.85 M(-43.9%) |
| Dec 2021 | $138.70 M(-53.2%) | $138.70 M(-16.3%) |
| Sept 2021 | - | $165.68 M(-5.8%) |
| June 2021 | - | $175.88 M(+34.1%) |
| Mar 2021 | - | $131.15 M(-55.8%) |
| Dec 2020 | $296.61 M(+561.8%) | $296.61 M(+158.4%) |
| Sept 2020 | - | $114.77 M(+481.2%) |
| June 2020 | - | $19.75 M(-55.9%) |
| Dec 2019 | $44.81 M(+149.7%) | $44.81 M |
| Dec 2018 | $17.95 M | - |
FAQ
- What is Praxis Precision Medicines annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Praxis Precision Medicines?
- What is Praxis Precision Medicines annual cash & cash equivalents year-on-year change?
- What is Praxis Precision Medicines quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Praxis Precision Medicines?
- What is Praxis Precision Medicines quarterly cash and cash equivalents year-on-year change?
What is Praxis Precision Medicines annual cash & cash equivalents?
The current annual cash & cash equivalents of PRAX is $81.30 M
What is the all time high annual cash & cash equivalents for Praxis Precision Medicines?
Praxis Precision Medicines all-time high annual cash & cash equivalents is $296.61 M
What is Praxis Precision Medicines annual cash & cash equivalents year-on-year change?
Over the past year, PRAX annual cash & cash equivalents has changed by +$19.68 M (+31.95%)
What is Praxis Precision Medicines quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of PRAX is $168.65 M
What is the all time high quarterly cash and cash equivalents for Praxis Precision Medicines?
Praxis Precision Medicines all-time high quarterly cash and cash equivalents is $296.61 M
What is Praxis Precision Medicines quarterly cash and cash equivalents year-on-year change?
Over the past year, PRAX quarterly cash and cash equivalents has changed by +$67.56 M (+66.83%)